Pascual, C., Mingot Castellano, M. E., Kerguelen Fuentes, A. E., García-Arroba Peinado, J., Cid, J., Jiménez, M., & VALCARCEL, D. (2022). Real-world effectiveness of caplacizumab vs the standard of care in immune thrombotic thrombocytopenic purpura.
Citación estilo ChicagoPascual, Cristina, María Eva Mingot Castellano, Ana Esther Kerguelen Fuentes, José García-Arroba Peinado, Joan Cid, Moraima Jiménez, y DAVID VALCARCEL. Real-world Effectiveness of Caplacizumab Vs the Standard of Care in Immune Thrombotic Thrombocytopenic Purpura. 2022.
Cita MLAPascual, Cristina, et al. Real-world Effectiveness of Caplacizumab Vs the Standard of Care in Immune Thrombotic Thrombocytopenic Purpura. 2022.
Precaución: Estas citas no son 100% exactas.